J&J receives subpoenas

Share this article:
US attorneys in Boston, Philadelphia and San Francisco have issued subpoenas to Johnson & Johnson for marketing materials involving three of its subsidiaries—Ortho-McNeil for Topamax, Janssen for Risperdal  and Scios for Natrecor.

J&J said the subpoenas seek information on its corporate supervision and oversight of the subsidiaries. A J&J statement said the company will cooperate.

Janssen, which increased Risperdal sales by 18% to $4.18 billion last year, received a subpoena in 2005 seeking information about the drug’s marketing and adverse reactions. Less than two years earlier, it received a subpoena from the Office of Personnel Management’s inspector-general seeking similar documents.

J&J’s Ortho-McNeil subsidiary, which increased Topamax sales by 21% to $2.03 billion last year, received a subpoena from the US Attorney’s Office in 2003 seeking documents relating to the drug’s marketing, including alleged “off-label” marketing, and a second subpoena last June.

In 2005, Scios received a subpoena from the US Attorney’s Office seeking documents regarding the sales and marketing of Natrecor, and Scios is responding to the subpoena, J&J said in the SEC filing.
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.